These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22937056)

  • 21. Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease.
    James AJ; Reinius LE; Verhoek M; Gomes A; Kupczyk M; Hammar U; Ono J; Ohta S; Izuhara K; Bel E; Kere J; Söderhäll C; Dahlén B; Boot RG; Dahlén SE;
    Am J Respir Crit Care Med; 2016 Jan; 193(2):131-42. PubMed ID: 26372680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum YKL-40 levels correlate with infarct volume, stroke severity, and functional outcome in acute ischemic stroke patients.
    Park HY; Jun CD; Jeon SJ; Choi SS; Kim HR; Choi DB; Kwak S; Lee HS; Cheong JS; So HS; Lee YJ; Park DS
    PLoS One; 2012; 7(12):e51722. PubMed ID: 23272150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chitinase 3-like 1 gene-329G/A polymorphism, plasma concentration and risk of coronary heart disease in a Chinese population.
    Xie F; Qian Q; Chen Z; Ma G; Feng Y
    Gene; 2012 May; 499(1):135-8. PubMed ID: 22433444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function.
    Ober C; Tan Z; Sun Y; Possick JD; Pan L; Nicolae R; Radford S; Parry RR; Heinzmann A; Deichmann KA; Lester LA; Gern JE; Lemanske RF; Nicolae DL; Elias JA; Chupp GL
    N Engl J Med; 2008 Apr; 358(16):1682-91. PubMed ID: 18403759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A polymorphism associated with increased levels of YKL-40 and the risk of early onset of lone atrial fibrillation.
    Henningsen KM; Olesen MS; Sajadieh G; Haunsoe S; Svendsen JH
    J Negat Results Biomed; 2013 Jan; 12():1. PubMed ID: 23279705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure.
    Harutyunyan M; Christiansen M; Johansen JS; Køber L; Torp-Petersen C; Kastrup J
    Immunobiology; 2012 Jun; 217(6):652-6. PubMed ID: 22209156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
    Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
    Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic value of YKL-40 concentrations in nonmyeloablative conditioning allogeneic hematopoietic cell transplantation.
    Mørup AM; Kornblit B; Johansen JS; Masmas TN; Madsen HO; Vindeløv L; Garred P
    Biol Blood Marrow Transplant; 2011 Sep; 17(9):1299-307. PubMed ID: 21232622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease.
    Hector A; Kormann MS; Mack I; Latzin P; Casaulta C; Kieninger E; Zhou Z; Yildirim AÖ; Bohla A; Rieber N; Kappler M; Koller B; Eber E; Eickmeier O; Zielen S; Eickelberg O; Griese M; Mall MA; Hartl D
    PLoS One; 2011; 6(9):e24399. PubMed ID: 21949714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CHI3L1 polymorphisms, cord blood YKL-40 levels and later asthma development.
    Usemann J; Frey U; Mack I; Schmidt A; Gorlanova O; Röösli M; Hartl D; Latzin P
    BMC Pulm Med; 2016 May; 16(1):81. PubMed ID: 27193312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection.
    Berres ML; Papen S; Pauels K; Schmitz P; Zaldivar MM; Hellerbrand C; Mueller T; Berg T; Weiskirchen R; Trautwein C; Wasmuth HE
    J Hepatol; 2009 Feb; 50(2):370-6. PubMed ID: 19070929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality.
    Mygind ND; Iversen K; Køber L; Goetze JP; Nielsen H; Boesgaard S; Bay M; Johansen JS; Nielsen OW; Kirk V; Kastrup J
    J Intern Med; 2013 Feb; 273(2):205-16. PubMed ID: 23140269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. YKL-40 and alcoholic liver and pancreas damage and disease in 86,258 individuals from the general population: cohort and mendelian randomization studies.
    Kjaergaard AD; Bojesen SE; Nordestgaard BG; Johansen JS
    Clin Chem; 2014 Nov; 60(11):1429-40. PubMed ID: 25225167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. YKL-40 in Asthma and its correlation with different clinical parameters.
    Saba M; Sharif MR; Akbari H; Nikoueinejad H; Ramazani Jolfaii M
    Iran J Allergy Asthma Immunol; 2014 Aug; 13(4):271-7. PubMed ID: 24659163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. YKL-40: may be use as a new inflammatory biomarker in obstructive sleep apnea syndrome?
    Duru S; Yüce G; Fırat H; Şimşek B; Uçar F; Ardıç S; Kurt EB
    Tuberk Toraks; 2015 Sep; 63(3):158-64. PubMed ID: 26523896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. YKL-40 as a clinical biomarker in adult patients with CF: Implications of a CHI3L1 single nucleotide polymorphism in disease severity.
    Coriati A; Bouvet GF; Massé C; Ducruet T; Berthiaume Y
    J Cyst Fibros; 2021 Nov; 20(6):e93-e99. PubMed ID: 33277205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of CHI3L1 gene variants with YKL-40 levels and hypertension incidence: A population-based nested case-control study in China.
    Xu T; Zheng X; Wang A; Guo Z; Zhang Y
    J Cell Mol Med; 2021 Jan; 25(2):919-924. PubMed ID: 33280245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis.
    Cantó E; Reverter F; Morcillo-Suárez C; Matesanz F; Fernández O; Izquierdo G; Vandenbroeck K; Rodríguez-Antigüedad A; Urcelay E; Arroyo R; Otaegui D; Olascoaga J; Saiz A; Navarro A; Sanchez A; Domínguez C; Caminero A; Horga A; Tintoré M; Montalban X; Comabella M
    Mult Scler; 2012 Jul; 18(7):983-90. PubMed ID: 22183936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. YKL-40 is correlated with FEV1 and the asthma control test (ACT) in asthmatic patients: influence of treatment.
    Lai T; Chen M; Deng Z; L Y; Wu D; Li D; Wu B
    BMC Pulm Med; 2015 Jan; 15():1. PubMed ID: 25578181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease.
    Holmgaard DB; Mygind LH; Titlestad IL; Madsen H; Pedersen SS; Johansen JS; Pedersen C
    BMC Pulm Med; 2013 Dec; 13():77. PubMed ID: 24373580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.